Page 97 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

76 PART I The Biology and Pathogenesis of Cancer

26. McSporran KD: Histologic grade predicts recurrence for margin- 46. Hanahan D, Weinberg RA: Hallmarks of cancer: the next genera-
ally excised canine subcutaneous soft tissue sarcomas, Vet Pathol tion, Cell 144:646–674, 2011.
46:928–933, 2009. 47. Nagamine E, Hirayama K, Matsuda K, et al.: Invasive front grading
VetBooks.ir 27. Berlato D, Murphy S, Monti P, et al.: Comparison of mitotic index and epithelial-mesenchymal transition in canine oral and cutane-
ous squamous cell carcinomas, Vet Pathol 54:783–791, 2017.
and Ki67 index in the prognostication of canine cutaneous mast
cell tumours, Vet Comp Oncol 13:143–150, 2015.
treatment biopsy for grading soft tissue sarcomas in dogs, Vet Comp
28. van Lelyveld S, Warland J, Miller R, et al.: Comparison between 48. Perry JA, Culp WT, Dailey DD, et al.: Diagnostic accuracy of pre-
Ki-67 index and mitotic index for predicting outcome in canine Oncol 12:106–113, 2014.
mast cell tumours, J Small Anim Pract 56:312–319, 2015. 49. Shaw T, Kudnig ST, Firestone SM: Diagnostic accuracy of pre-
29. Dennis MM, McSporran KD, Bacon NJ, et al.: Prognostic factors treatment biopsy for grading cutaneous mast cell tumours in dogs,
for cutaneous and subcutaneous soft tissue sarcomas in dogs, Vet Vet Comp Oncol 16:214–219, 2018.
Pathol 48:73–84, 2011. 50. Webster JD, Dennis MM, Dervisis N, et al.: Recommended guide-
30. Edmondson EF, Hess AM, Powers BE: Prognostic significance of lines for the conduct and evaluation of prognostic studies in veteri-
histologic features in canine renal cell carcinomas. 70 nephrecto- nary oncology, Vet Pathol 48:7–18, 2011.
mies, Vet Pathol 52:260–268, 2015. 51. Kirpensteijn J, Kik M, Rutteman GR, et al.: Prognostic significance
31. Meuten DJ, Moore FM, George JW: Mitotic count and the field of of a new histologic grading system for canine osteosarcoma, Vet
view area. time to standardize, Vet Pathol 53:7–9, 2016. Pathol 39:240–246, 2002.
32. Valli VE, Kass PH, San Myint M, et al.: Canine lymphomas. asso- 52. Loukopoulos P, Robinson WE: Clinicopathological relevance of
ciation of classification type, disease stage, tumor subtype, mitotic tumour grading in canine osteosarcoma, J Comp Pathol 136:65–73,
rate, and treatment with survival, Vet Pathol 50:738–748, 2013. 2007.
33. Laprie C, Abadie J, Amardeilh MF, et al.: MIB-1 immunoreactivity 53. Dernell WS, Straw RC, Cooper MF, et al.: Multilobular osteo-
correlates with biologic behaviour in canine cutaneous melanoma, chondrosarcoma in 39 dogs: 1979-1993, J Am Anim Hosp Assoc
Vet Dermatol 12:139–147, 2001. 34:11–18, 1998.
34. Weishaar KM, Thamm DH, Worley DR, et al.: Correlation 54. Straw RC, LeCouteur RA, Powers BE, et al.: Multilobular osteo-
of nodal mast cells with clinical outcome in dogs with mast cell chondrosarcoma of the canine skull: 16 cases (1978-1988), J Am
tumour and a proposed classification system for the evaluation of Vet Med Assoc 195:1764–1769, 1989.
node metastasis, J Comp Pathol 151:329–338, 2014. 55. Straw RC, Powers BE, Klausner J, et al.: Canine mandibular osteo-
35. Gloyeske NC, Goreal W, O’Neil M, et al.: Outcomes of breast sarcoma: 51 cases (1980-1992), J Am Anim Hosp Assoc 32:257–
cancer patients with micrometastasis and isolated tumor cells in 262, 1996.
sentinel lymph nodes, Mod Pathol 24:40a–41a, 2011. 56. Farese JP, Kirpensteijn J, Kik M, et al.: Biologic behavior and clini-
36. van der Heiden-van der Loo M, Schaapveld M, Ho VKY, et al.: cal outcome of 25 dogs with canine appendicular chondrosarcoma
Outcomes of a population-based series of early breast cancer treated by amputation: a Veterinary Society of Surgical Oncology
patients with micrometastases and isolated tumour cells in axillary retrospective study, Vet Surg 38:914–919, 2009.
lymph nodes, Ann Oncol 24:2794–2801, 2013. 57. Ogilvie GK, Powers BE, Mallinckrodt CH, et al.: Surgery and
37. Ahmed SS, Thike AA, Iqbal J, et al.: Sentinel lymph nodes with iso- doxorubicin in dogs with hemangiosarcoma, J Vet Intern Med
lated tumour cells and micrometastases in breast cancer: clinical rel- 10:379–384, 1996.
evance and prognostic significance, J Clin Pathol 67:243–250, 2014. 58. Carpenter LG, Withrow SJ, Powers BE, et al.: Squamous-cell car-
38. Sloothaak DAM, van der Linden RLA, van De Velde CJH, et al.: cinoma of the tongue in 10 dogs, J Am Anim Hosp Assoc 29:17–24,
Prognostic implications of occult nodal tumour cells in stage I and 1993.
II colon cancer. The correlation between micrometastasis and dis- 59. Spangler WL, Culbertson MR, Kass PH: Primary mesenchymal
ease recurrence, Eur J Surg Oncol 43:1456–1462, 2017. (nonangiomatous/nonlymphomatous) neoplasms occurring in the
39. Sloothaak DA, Sahami S, van der Zaag-Loonen HJ, et al.: The canine spleen: anatomic classification, immunohistochemistry, and
prognostic value of micrometastases and isolated tumour cells in mitotic activity correlated with patient survival, Vet Pathol 31:37–
histologically negative lymph nodes of patients with colorectal 47, 1994.
cancer: a systematic review and meta-analysis, Eur J Surg Oncol 60. McNiel EA, Ogilvie GK, Powers BE, et al.: Evaluation of prog-
40:263–269, 2014. nostic factors for dogs with primary lung tumors: 67 cases (1985-
40. Beer P, Pozzi A, Rohrer Bley C, et al.: The role of sentinel lymph 1992), J Am Vet Med Assoc 211:1422–1427, 1997.
node mapping in small animal veterinary medicine:a comparison 61. Wilcock BP, Peiffer RL: Morphology and behavior of primary ocu-
with current approaches in human medicine, Vet Comp Oncol lar melanomas in 91 dogs, Vet Pathol 23:418–424, 1986.
16:178–187, 2018. 62. Gower KL, Liptak JM, Culp WT, et al.: Splenic liposarcoma in
41. Casey KM, Steffey MA, Affolter VK: Identification of occult dogs: 13 cases (2002-2012), J Am Vet Med Assoc 247:1404–1407,
micrometastases and isolated tumour cells within regional lymph 2015.
nodes of previously diagnosed non-metastatic (stage 0) canine car- 63. Burton JH, Powers BE, Biller BJ: Clinical outcome in 20 cases of
cinomas, Vet Comp Oncol 15:785–792, 2017. lingual hemangiosarcoma in dogs: 1996-2011, Vet Comp Oncol
42. Wong YP, Shah SA, Shaari N, et al.: Comparative analysis between 12:198–204, 2014.
multilevel sectioning with conventional haematoxylin and eosin 64. Molander-McCrary H, Henry CJ, Potter K, et al.: Cutaneous mast
staining and immunohistochemistry for detecting nodal microme- cell tumors in cats: 32 cases (1991-1994), J Am Anim Hosp Assoc
tastases with stage I and II colorectal cancers, Asian Pac J Cancer 34:281–284, 1998.
Prev 15:1725–1730, 2014. 65. Wilcock BP, Yager JA, Zink MC: The morphology and behavior of
43. Meuten D, Munday JS, Hauck M: Time to standardize? Time to feline cutaneous mastocytomas, Vet Pathol 23:320–324, 1986.
validate? Vet Pathol 55:195–199, 2018. 66. Hahn KA, McEntee MF: Prognosis factors for survival in cats after
44. Northrup NC, Harmon BG, Gleger TL, et al.: Variation among removal of a primary lung tumor: 21 cases (1979-1994), Vet Surg
pathologists in histologic grading of canine cutaneous mast cell 27:307–311, 1998.
tumors, J Vet Diagn Invest 17:245–248, 2005. 67. Weijer K, Head KW, Misdorp W, et al.: Feline malignant mam-
45. Valli VE, San Myint M, Barthel A, et al.: Classification of canine mary tumors. I. Morphology and biology: some comparisons
malignant lymphomas according to the world health organization with human and canine mammary carcinomas, J Natl Cancer Inst
criteria, Vet Pathol 48:198–211, 2011. 49:1697–1704, 1972.